|
EP3801610A1
|
|
Viral particle - based vaccine
|
|
AU2016203029A1
|
|
Composition containing hcmv particles
|
|
EP3090757A1
|
|
Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer
|
|
AU2014210617A1
|
|
Combination of a recombinant mycobacterium and a biologically active agent as a vaccine
|
|
AU2012201925A1
|
|
Combination of a recombinant mycobacterium and a biologically active agent as a vaccine
|
|
WO2012038348A1
|
|
Recombinant mycobacterium as vaccine for use in humans
|
|
WO2011124371A1
|
|
Viral particle released after infection of mammalian cells by human cytomegalovirus (hcmv) containing a fusion protein and use thereof
|
|
WO2012069067A1
|
|
Method for producing an immunotherapeutic agent
|
|
EP2431051A1
|
|
Type-1 interferons for the treatment of multiple sclerosis
|
|
EP2144627A1
|
|
Composition containing hcmv particles
|
|
EP1944313A1
|
|
Recombinant malaria vaccine
|
|
EP1649869A1
|
|
Combination of a recombinant mycobacterium and a biologically active agent as a vaccine
|
